GAS5 and inflammatory bowel disease: Future investigations should be assessed in a larger cohort to profoundly investigate the molecular mechanisms undergoing the role of GAS5-AS1 in the IBD pathogenesis, highlighting the possible role of GAS5-AS1 as a potential diagnostic biomarker and its possible implications in the development of innovative IBD treatment strategies, particularly to guide glucocorticoids (GC) therapy and to determine steroids effectiveness, thanks to the ability of GAS5-AS1 to modulate GAS5, which is implicated in GC response.